ARRAY COMPARATIVE GENOMIC HYBRIDIZATION: A NEW GENOMIC APPROACH FOR HIGH-RESOLUTION ANALYSIS OF COPY NUMBER CHANGES
Dimova Iv
*Corresponding Author: Dr. Ivanka Dimova, Department of Medical Genetics, Medical University Sofia, 2 Zdrave str, 1431 Sofia, Bulgaria; Tel.Fax: +359-2-952-03-57; E-mail: idimova73@yahoo.com
page: 11

ARRAY COMPARATIVE GENOMIC HYBRIDIZATION PERFORMANCE

Several different array platforms have been used for CGH measurements in mammalian genomes. The initial step is selection and preparation of the clones. Various approaches have used large insert genomic clones such as bacterial artificial chromosomes (BACs) [4], as well as cDNA clones and oligonucleotides for array spots [3,7].

      The BAC clones are thought to be superior to cDNAs and oligonucleotides as aCGH probes because their large genomic size (~150 Kb) confers high and consistent binding specifity [8]. The use of BACs for aCGH provide sufficiently intense signals so that accurate measurements can be obtained over a wide range in copy number from below single-copy level to at least two orders of magnitude higher (for amplifications of at least 1,000-fold) [9]. Thus, the precision of measurement is such that single copy changes affecting individual clones on the array can be readily detected [4] and aberration boundaries can be located to within a fraction of the length of a BAC [10]. Arrays described in early reports of aCGH used whole BACs isolated from large bacterial cultures, and the DNA was often sonicated to reduce the molecular mass [9,11, 12]. Since growth and processing of large bacterial cultures is not practical for large analysis, methods have been devised that use representations of BACs prepared by ligation-mediated polymerase chain reaction (PCR) [4,13], degenerate oligonucleotide primed PCR (DOP-PCR) [5] or a modified DOP-PCR protocol [14]. If the complexity and sequence balance of the source clones is maintained, the BAC representation is expected to yield sufficiently intense signals to perform as well as whole BACs.

      Arrays that contain spots made from cDNAs [15] or oligonucleotides were initially produced to measure gene expression. The cDNA arrays can detect amplified sequences using several micrograms of genomic DNA isolated from cell lines and frozen tissues [3,7]. The large changes in copy number provide enough signal so that boundaries of the amplicons can be determined with the highest resolution because the amplification status of individual array elements could be determined.

      Analyses of genomes by aCGH have employed arrays focused on: i) a particular region of the genome [7]; ii) selected regions known to be frequently aberrant in tumors [16]; and iii) genome-wide arrays [17,18]. In all cases, the enhanced resolution possible with aCGH compared with chromosome CGH, has demonstrated copy number aberrations not evident using chromosome CGH.

      The PCR products are arrayed in triplicate (custom arrays) or duplicate (1 Mb-resolution whole genome array) onto amine-binding slides. The procedure of aCGH includes the following steps: digestion of genomic DNA; labeling of genomic DNA by random priming; purification of labeled products; precipitation in the presence of blocking DNA; hybridization to microarrays; image and data analysis [3-5].

      For data analysis, global intensities of fluorescence signals for test (T) and reference (N) DNA are normalized with the entire set of spots on the array, the T:N ratios are calculated, the median values of replicate spots are calculated, and these values are used to define the selection threshold for individual spots. The profiles are represented with log 2 values of the ratios on the Y-axis and with the values of Mb position of the clones along the chromosome on the X-axis (Fig. 1) [3-5].




Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006